Syndetics cover image
Image from Syndetics

Merck & Co : after Vioxx, the government and the pharmaceutical industry reconsider the balance between innovation, safety, and cost / Jaan Elias, Spencer Hutchins & Andrea Nagy.

By: Contributor(s): Material type: TextSeries: Publisher: [London] : SAGE, 2016Description: 1 online resource : illustrations (black and white, and colour)Content type:
  • text
  • still image
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781473974401 (ebook) :
Subject(s): DDC classification:
  • 658.4056 23
Online resources: Merck & Co. had built an enviable reputation not just as a paragon of the pharmaceutical industry but as one of America's most admired businesses. The company had produced medical breakthrough after medical breakthrough, engaged in extensive philanthropy, and instituted progressive human resources policies, all the while delivering stellar financial performance. And yet, after withdrawing its blockbuster drug Vioxx in September of 2004, Merck found its reputation and its financial stability in danger. This case examines the challenges that faced Merck in the wake of the Vioxx recall.
No physical items for this record

Originally Published in: Elias, J., Hutchins, S., & Nagy, A. (2006). Merck & Co. After Vioxx, the Government and the Pharmaceutical Industry Reconsider the Balance between Innovation, Safety, and Cost. 06-013. New Haven, CT: Yale School of Management, Yale University.

Merck & Co. had built an enviable reputation not just as a paragon of the pharmaceutical industry but as one of America's most admired businesses. The company had produced medical breakthrough after medical breakthrough, engaged in extensive philanthropy, and instituted progressive human resources policies, all the while delivering stellar financial performance. And yet, after withdrawing its blockbuster drug Vioxx in September of 2004, Merck found its reputation and its financial stability in danger. This case examines the challenges that faced Merck in the wake of the Vioxx recall.

Description based on online resource; title from home page (viewed on May 3, 2016).

Licensed e-book